Your browser is no longer supported. Please, upgrade your browser.
MNK Mallinckrodt plc daily Stock Chart
Mallinckrodt plc
Index- P/E- EPS (ttm)-41.47 Insider Own1.50% Shs Outstand88.27M Perf Week-5.42%
Market Cap723.81M Forward P/E1.03 EPS next Y7.96 Insider Trans0.72% Shs Float81.37M Perf Month-11.64%
Income-3454.30M PEG- EPS next Q2.10 Inst Own- Short Float44.02% Perf Quarter-62.21%
Sales3.25B P/S0.22 EPS this Y-421.90% Inst Trans2.72% Short Ratio11.13 Perf Half Y-59.06%
Book/sh36.57 P/B0.22 EPS next Y-3.61% ROA-26.70% Target Price14.31 Perf Year-62.12%
Cash/sh2.56 P/C3.21 EPS next 5Y9.17% ROE-72.20% 52W Range8.00 - 36.65 Perf YTD-48.10%
Dividend- P/FCF1.06 EPS past 5Y6.29% ROI-36.70% 52W High-77.63% Beta2.29
Dividend %- Quick Ratio1.10 Sales past 5Y14.30% Gross Margin44.90% 52W Low2.50% ATR0.53
Employees3700 Current Ratio1.50 Sales Q/Q4.70% Oper. Margin- RSI (14)33.14 Volatility6.18% 6.17%
OptionableYes Debt/Eq1.91 EPS Q/Q855.80% Profit Margin- Rel Volume0.73 Prev Close8.42
ShortableYes LT Debt/Eq1.90 EarningsAug 06 BMO Payout- Avg Volume3.22M Price8.20
Recom3.00 SMA20-7.09% SMA50-22.76% SMA200-58.53% Volume2,371,987 Change-2.61%
Jun-11-19Initiated Barclays Equal Weight
May-31-19Downgrade Piper Jaffray Overweight → Neutral
May-22-19Downgrade Jefferies Buy → Hold
Mar-20-19Initiated SunTrust Hold
Nov-19-18Upgrade Canaccord Genuity Hold → Buy $34 → $40
Sep-11-18Downgrade Goldman Neutral → Sell
Aug-24-18Reiterated B. Riley FBR Neutral $20 → $37
Aug-08-18Reiterated Stifel Hold $18 → $30
Aug-08-18Downgrade Raymond James Outperform → Mkt Perform
May-09-18Reiterated Barclays Underweight $20 → $12
May-02-18Initiated B. Riley FBR, Inc. Neutral $15
Mar-09-18Reiterated Mizuho Neutral $21 → $16
Feb-02-18Downgrade Barclays Equal Weight → Underweight $23 → $20
Jan-09-18Reiterated Mizuho Neutral $22 → $21
Jan-03-18Initiated Leerink Partners Mkt Perform $26
Nov-08-17Reiterated Canaccord Genuity Buy $38 → $24
Nov-08-17Downgrade Wells Fargo Outperform → Market Perform
Nov-08-17Downgrade Goldman Buy → Neutral
Nov-08-17Downgrade Barclays Overweight → Equal Weight $65 → $23
Nov-07-17Downgrade Deutsche Bank Buy → Hold $44 → $28
Jul-16-19 05:20PM  Mallinckrodt Halts Phase 2B Trial Investigating the Use of Acthar® Gel (Repository Corticotropin Injection) in Amyotrophic Lateral Sclerosis (ALS) PR Newswire
Jul-15-19 10:10AM  Will Mallinckrodt (MNK) Beat Estimates Again in Its Next Earnings Report? Zacks
Jul-10-19 12:00PM  How St. Louis stocks compare with stocks nationally American City Business Journals
Jul-01-19 06:55AM  Mallinckrodt to Report Earnings Results for Second Quarter 2019 PR Newswire
Jun-28-19 05:50PM  Mallinckrodt (MNK) Outpaces Stock Market Gains: What You Should Know Zacks
Jun-25-19 07:42AM  Drug maker stocks rally after AbbVie's deal to buy Allergan for 45% premium MarketWatch
Jun-24-19 06:55AM  Mallinckrodt Achieves 50 Percent Enrollment for Phase 2B Trial Investigating the Use of Acthar® Gel (Repository Corticotropin Injection) in Amyotrophic Lateral Sclerosis (ALS) PR Newswire -6.13%
06:00AM  The U.S. Gets Hundreds of Millions From Big Pharma in Co-Pay Settlements
Jun-14-19 08:29AM  Mallinckrodt Presents Encouraging Data on Acthar Gel for RA Zacks -5.79%
Jun-13-19 06:45AM  All Primary and Secondary Outcome Targets Met in Mallinckrodt's Phase 4 Acthar® Gel (Repository Corticotropin Injection) Rheumatoid Arthritis (RA) Clinical Trial (n=259) with Data Presented at the European Congress of Rheumatology 2019 (EULAR) PR Newswire +5.69%
Jun-11-19 06:55AM  Mallinckrodt to Present at BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference PR Newswire
Jun-06-19 04:41PM  Mallinckrodt Down After Agreement with DOJ for Litigation Zacks
09:31AM  Why Is Mallinckrodt (MNK) Down 47.4% Since Last Earnings Report? Zacks
Jun-05-19 05:10PM  Mallinckrodt Agrees To Pay $15.4M In DOJ Settlement Over Acthar Subsidies Benzinga -7.93%
01:59PM  Mallinckrodt's stock falls after it expects to pay more than $15 million to resolve DOJ investigation MarketWatch
12:46PM  Mallinckrodt Announces Agreement In Principle With U.S. Department Of Justice On Legacy Questcor Sales And Marketing Activities; Responds To Government Civil Litigation Involving Legacy Questcor Charitable Foundation Activities PR Newswire
May-31-19 05:37PM  RM LAW Announces Investigation of Mallinckrodt plc PR Newswire
11:29AM  Mallinckrodt Stock is Falling Because the Wheels Might Finally Come Off
06:55AM  Mallinckrodt to Present at Raymond James Life Sciences and Medtech Conference PR Newswire
May-30-19 07:48AM  Cara Shares Up on Positive Phase III Data for Itchiness Drug Zacks
May-29-19 10:40AM  Mallinckrodt to Spin Off Specialty Generics Unit, Shares Down Zacks
06:55AM  Mallinckrodt Announces Positive Open-Label Results from Phase 4 Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Rheumatoid Arthritis (RA) to be Presented at the European Congress of Rheumatology 2019 (EULAR) PR Newswire
May-28-19 12:43PM  Mallinckrodt's Amitiza to stay with branded business after spin-off Reuters
09:31AM  Mallinckrodt Rises After Announcing Plans to Spin Off Specialty Generics Unit
07:10AM  Mallinckrodt to spin-off generics business, keep constipation drug Reuters
06:45AM  Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders PR Newswire
May-23-19 07:57PM  Cramer Remix: Why Chipotle's downgrade is misguided CNBC
07:14PM  Cramer: Mallinckrodt is too risky and not worth speculating on CNBC Videos
12:07PM  This May Hurt a Little (Or a Lot) as Opioids Haunt Pharma Bonds Bloomberg
May-22-19 03:42PM  Mallinckrodt (MNK) Down After Filing Suit Against HHS and CMS Zacks -6.48%
02:43PM  Wolf Popper LLP Announces Investigation on Behalf of Investors in Mallinckrodt plc PR Newswire
11:26AM  Mallinckrodt Slumps After Filing Acthar Lawsuit, But BMO Says It Can Take The Hit Benzinga
11:15AM  Mallinckrodt Stock Could Take Another Plunge, Analyst Says
07:11AM  Mallinckrodt shares crater after drug maker files suit to protect Medicaid patient access to Acthar MarketWatch
06:00AM  LOST MONEY IN MALLINCKRODT? Gibbs Law Group Investigates Potential Securities Claims on Behalf of Investors Business Wire
May-21-19 07:56PM  Edited Transcript of MNK earnings conference call or presentation 7-May-19 12:30pm GMT Thomson Reuters StreetEvents -24.25%
05:39PM  Mallinckrodt International Finance SA -- Moody's downgrades Mallinckrodt's CFR to B2; outlook remains negative Moody's
04:40PM  Why J.C. Penney, Mallinckrodt, and BioCryst Pharmaceuticals Slumped Today Motley Fool
04:30PM  Mallinckrodt Announces Election of Carlos V. Paya, M.D., Ph.D. to its Board of Directors PR Newswire
04:19PM  Mallinckrodt Shares Fall 25%: What You Need To Know Benzinga
03:18PM  Mallinckrodt Is Circling the Drain - Do Not Go Down With It
03:13PM  Mallinckrodt Investigated by Block & Leviton LLP For Violations of Federal Securities Laws GlobeNewswire
01:41PM  Mallinckrodt Plunge to Record Low Is a Win for Short Sellers Bloomberg
12:43PM  Mallinckrodt Tumbles After Filing a Lawsuit Against the HHS on Acthar Gel
12:20PM  Why Mallinckrodt Stock Is Tanking Today Motley Fool
07:42AM  UPDATE: Mallinckrodt stock slides 10% premarket after it files suit over Medicaid patient access to Acthar gel MarketWatch
06:59AM  Mallinckrodt Files Suit against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) to Protect Medicaid Patient Access to Acthar® Gel PR Newswire
May-17-19 07:41AM  Coatue Managements Latest Moves Insider Monkey
May-15-19 11:07AM  Mallinckrodt Ends Enrollment in Phase III for Terlipressin Zacks
May-14-19 10:17AM  Here's Why Generic-Drug Manufacturers Were Down Monday Motley Fool
06:55AM  Mallinckrodt Completes Enrollment of Phase 3 Terlipressin CONFIRM Trial PR Newswire
May-13-19 05:21PM  Lifshitz & Miller LLP Announces Investigation of Glencore plc, Kingstone Companies, Inc., Mallinckrodt PLC, Metro Bank PLC, Momo Inc., Nabriva Therapeutics PLC, National General Holdings Corp, and Zillow Group, Inc. PR Newswire -7.12%
May-08-19 04:00PM  Mallinckrodt (MNK) Beats on Q1 Earnings & Sales, Raises View Zacks +5.59%
01:24AM  Mallinckrodt (MNK) Q1 2019 Earnings Call Transcript Motley Fool
May-07-19 08:22AM  Mallinckrodt stock swings up 16%, then down, after drugmaker beats earnings estimates and raises 2019 profit outlook CNBC
07:35AM  Mallinckrodt (MNK) Surpasses Q1 Earnings and Revenue Estimates Zacks
06:43AM  Mallinckrodt's stock soars after profit and sales beat, raised guidance MarketWatch
06:14AM  Mallinckrodt: 1Q Earnings Snapshot Associated Press
06:00AM  Mallinckrodt plc Reports Strong Growth in First Quarter 2019 Results, Raises Guidance for 2019, and Continues to Make Significant Advancements in Pipeline and Data Generation PR Newswire
06:00AM  Cancer Prevention Pharmaceuticals (CPP) and Mallinckrodt Announce Results from Pivotal Phase 3 Trial of CPP-1X/Sulindac in Patients with Familial Adenomatous Polyposis PR Newswire
May-06-19 06:45AM  Mallinckrodt Announces Encouraging Interim Analysis Results in Phase 4 Registry of INOmax® (Nitric Oxide) Gas for Inhalation for Pulmonary Hypertension in Neonates PR Newswire
May-02-19 12:56PM  MALLINCKRODT (MNK) ALERT: Johnson Fistel, LLP Commences Investigation of Mallinckrodt PLC; Encourages all Investors to Contact the Firm for Information PR Newswire
06:55AM  Mallinckrodt to Present Open-Label Results from Phase 4 Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Patients with Rheumatoid Arthritis at Annual European Congress of Rheumatology (EULAR 2019) PR Newswire
06:00AM  Investors Pressure Firms on Opioid Crisis Morningstar
May-01-19 09:00PM  Bragar Eagel & Squire, P.C. is Investigating Mallinckrodt plc (MNK) on Behalf of Stockholders and Encourages MNK Investors to Contact the Firm GlobeNewswire
06:07PM  Is a Beat in the Cards for Mallinckrodt (MNK) Q1 Earnings? Zacks
05:45PM  Mallinckrodt (MNK) Dips More Than Broader Markets: What You Should Know Zacks
12:58PM  Mallinckrodt Investigated by Block & Leviton LLP For Violations of Federal Securities Laws GlobeNewswire
Apr-30-19 05:15PM  Mallinckrodt shares drop after U.S. joins cases over expensive drug Reuters -15.61%
04:31PM  Why Diebold Nixdorf, Mallinckrodt, and Texas Roadhouse Slumped Today Motley Fool
02:00PM  Mallinckrodt shares drop after U.S. joins cases over expensive drug Reuters
12:48PM  Mallinckrodt shares drop after U.S. joins cases over expensive drug Reuters
12:39PM  Mallinckrodt shares drop after U.S. joins cases over expensive drug Reuters
10:32AM  Mallinckrodt (MNK) Earnings Expected to Grow: Should You Buy? Zacks
08:16AM  What's in the Cards for Bausch Health (BHC) Q1 Earnings? Zacks
Apr-29-19 02:52PM  Is Mallinckrodt plc (MNK) A Good Stock To Buy? Insider Monkey
Apr-26-19 09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
Apr-24-19 04:34PM  Mallinckrodt Completes Expansion of Operations and Manufacturing Facility for StrataGraft® Regenerative Skin Tissue in Madison, Wis. PR Newswire
02:16PM  Mallinckrodt International Finance SA -- Moody's downgrades Mallinckrodt's CFR to B1; outlook negative Moody's
Apr-23-19 06:45AM  Mallinckrodt Lupus Phase 4 Clinical Study for Acthar® Gel (Repository Corticotropin Injection) Completes Enrollment in Difficult-to-Manage Population PR Newswire
Apr-22-19 12:26PM  If You Had Bought Mallinckrodt (NYSE:MNK) Stock Five Years Ago, You'd Be Sitting On A 74% Loss, Today Simply Wall St.
Apr-18-19 06:45AM  Mallinckrodt Reports Top-Line Results from Proof-of-Concept Study of Nitric Oxide Gas in Ex-Vivo System of Human Lung Transplants PR Newswire
Apr-17-19 04:32PM  Why Sprint, Bank of New York Mellon, and Mallinckrodt Slumped Today Motley Fool -11.68%
Apr-16-19 05:50PM  Mallinckrodt (MNK) Stock Sinks As Market Gains: What You Should Know Zacks
10:10AM  Will Mallinckrodt (MNK) Beat Estimates Again in Its Next Earnings Report? Zacks
Apr-15-19 12:08PM  Dr. Reddy's (RDY) Inks Deal to Acquire Portfolio of 42 ANDAs Zacks
10:50AM  Mallinckrodt (MNK) Completes Enrollment in Skin Tissue Study Zacks
06:45AM  Data on Impact of Revised Consensus Recommendations on Time to Treatment and Serum Creatinine (SCr) at Treatment Start for Patients with Hepatorenal Syndrome Type 1 (HRS-1) Presented at the 2019 International Liver Congress (EASL) PR Newswire
Apr-12-19 10:48AM  Zacks Value Trader Highlights: G-III Apparel, General Motors, Legg Mason, Mallinckrodt and United Natural Foods Zacks
10:43AM featured expert Kevin Matras highlights: Mallinckrodt Public, Bayer Aktiengesellschaft, United Natural Foods, Tutor Perini and G-III Apparel Zacks
06:45AM  Mallinckrodt Completes Full Enrollment of its Phase 3 Clinical Trial for StrataGraft® Regenerative Skin Tissue PR Newswire
Apr-11-19 01:41PM  Lessons from my Favorite Book for Value Investors Zacks
08:17AM  6 Valuable Price-to-Book Stocks to Buy as Slowdown Lurks Zacks
06:45AM  Mallinckrodt and Washington University St. Louis Select First Collaborative Research Endeavor PR Newswire
Apr-10-19 09:30AM  MNK vs. AMPH: Which Stock Is the Better Value Option? Zacks
Apr-09-19 05:50PM  Mallinckrodt (MNK) Dips More Than Broader Markets: What You Should Know Zacks
09:15AM  Comeback Gives S&P an 8-Session Winning Streak Zacks
06:45AM  Data Published on Acthar® Gel (repository corticotropin injection) Disease Status and Utilization Patterns in Uveitis Patients in Journal of Ocular Pharmacology and Therapeutics PR Newswire
Apr-08-19 09:30AM  Has Mallinckrodt public limited (MNK) Outpaced Other Medical Stocks This Year? Zacks
09:10AM  Is Mallinckrodt (MNK) Stock Undervalued Right Now? Zacks
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza. The company markets branded pharmaceutical products for autoimmune and rare diseases in the specialty areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers H.P. Acthar Gel, an injectable drug for various indications, such as rheumatoid arthritis, multiple sclerosis, infantile spasms, systemic lupus erythematosus, polymyositis, and others; Inomax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an intravenous formulation of acetaminophen for pain management; and Therakos photopheresis, an immunotherapy treatment platform. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; StrataGraft, which is in Phase III and II clinical development for the treatment of burns; Stannsoporfin, a heme oxygenase inhibitor for the treatment of jaundice; Xenon gas for inhalation; MNK-6105 and MNK-6106, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; VTS-270 that is in Phase III development for Niemann-Pick Type C, a neurodegenerative disease; and CPP-1X/sulindac, which is in Phase III development for Familial Adenomatous Polyposis. It markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. It has collaboration with the Washington University School of Medicine in St. Louis. The company was founded in 1867 and is based in Staines-Upon-Thames, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Reasons Bryan M.EVP & CFOJun 07Buy8.965,40048,38317,979Jun 07 04:12 PM
Trudeau MarkPresident and CEOMay 30Buy9.262,00018,528233,254May 31 07:05 AM
Trudeau MarkPresident and CEOMay 09Buy16.331,00016,325231,254May 10 08:06 AM
Trudeau MarkPresident and CEOMar 05Buy22.651,00022,650229,252Mar 06 08:18 AM
Trudeau MarkPresident and CEODec 10Buy20.181,00020,180236,254Dec 11 08:30 AM